Candriam S.C.A. Isoray, Inc. Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding ISR
# of Institutions
3Shares Held
180KCall Options Held
0Put Options Held
0About Isoray, Inc.
- Ticker ISR
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 142,112,992
- Market Cap $98.1M
- Description
- Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...